Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-07-12
2005-07-12
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S257000, C514S217010, C544S115000, C544S251000, C540S594000
Reexamination Certificate
active
06916811
ABSTRACT:
Disclosed herein are compounds having the structural formula Aincluding pharmaceutically acceptable salts or solvates of said compound, wherein X, Y, Q and R are as defined in the specification; pharmaceutical compositions thereof; methods of treating central nervous system diseases by administering the compound of the present invention to a patient in need of such treatment, and processes for preparing the compound of this invention.
REFERENCES:
patent: 5935964 (1999-08-01), Baraldi et al.
patent: 6407236 (2002-06-01), Baraldi et al.
patent: 6448253 (2002-09-01), Baraldi
patent: 6630475 (2003-10-01), Neustadt et al.
patent: 2003/0144266 (2003-07-01), Baraldi et al.
patent: 2004/0023997 (2004-02-01), Neustadt et al.
patent: 2004/0039004 (2004-02-01), Baraldi et al.
patent: 2004/0220194 (2004-11-01), Neustadt et al.
patent: 0 856 003 (1998-08-01), None
patent: WO 95/01356 (1995-01-01), None
patent: WO 98/52568 (1998-11-01), None
patent: WO 00/15231 (2000-03-01), None
patent: WO 01/92264 (2001-12-01), None
Pecherer et al,J. Hetero. Chem., 8(1971), p. 779-783.
Shiozawa et al,Chem. Pharm. Bull., 32(1984), p. 2522-2529.
Ungersatdt et al,Brain Research, 24(1970), p. 485-93.
Ungerstadt,Eur. J. Pharmacol., 5(1968), p. 107-110.
Pier Giovanni Baraldi et al., Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine Derivatives: Potent and Selective A2AAdenosine Antagonists, J. Med. Chem., 1996, 39(5), 1164-1171.
Camille G. Wermuth, Molecular Variations Based on Isosteric Replacements, The Practice of Medicinal Chemistry, 1996, XP-002190259, 203-237.
Boyle Craig D.
Chackalamannil Samuel
Greenlee William J.
Shah Unmesh G.
Xia Yan
Berch Mark L.
Magatti Anita W.
Schering Corporation
LandOfFree
Adenosine A2a receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adenosine A2a receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine A2a receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3412726